Texas Capital Bancshares 5.75% Series B Preferred Stock
TCBIO
0 hedge funds and large institutions have $0 invested in Texas Capital Bancshares 5.75% Series B Preferred Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $9 → $0 (-$9)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
-$9 |
TCBIO Hedge Fund Activity: Q2 2024 in Review
0 of the 6,928 institutional investors tracked by Wall St. Rank reported a position in Texas Capital Bancshares 5.75% Series B Preferred Stock (TCBIO) for Q2 2024, worth a combined $0 — down 100% from $9 a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of TCBIO and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was FNY Investment Advisers, exiting entirely with an estimated $9 sold.
- 0 institutional investors held Texas Capital Bancshares 5.75% Series B Preferred Stock (TCBIO) as of Q2 2024, down from 1 in Q1 2024.
- Funds reported $0 of Texas Capital Bancshares 5.75% Series B Preferred Stock stock for Q2 2024, down 100% quarter-over-quarter.
- 0 funds opened new Texas Capital Bancshares 5.75% Series B Preferred Stock positions in Q2 2024 and 1 closed out, a net change of -1 holder.
- The largest Texas Capital Bancshares 5.75% Series B Preferred Stock seller in Q2 2024 was FNY Investment Advisers, an estimated $9 sold.
Based on aggregated 13F filings for Q2 2024.